Cargando…
Recurrent Spliceosome Mutations in Cancer: Mechanisms and Consequences of Aberrant Splice Site Selection
SIMPLE SUMMARY: The spliceosome ribonucleoprotein complex catalyzes the removal of introns and exons ligation, a fundamental post-transcriptional process that generates mature RNAs. Cancer-associated mutations in spliceosome components give rise to aberrant splice site selection and, therefore, the...
Autores principales: | Niño, Carlos A., Scotto di Perrotolo, Rossella, Polo, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773931/ https://www.ncbi.nlm.nih.gov/pubmed/35053445 http://dx.doi.org/10.3390/cancers14020281 |
Ejemplares similares
-
Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia
por: Shiozawa, Yusuke, et al.
Publicado: (2018) -
Clathrin light chain A drives selective myosin VI recruitment to clathrin-coated pits under membrane tension
por: Biancospino, Matteo, et al.
Publicado: (2019) -
Regulation of 3′ splice site selection after step 1 of splicing by spliceosomal C* proteins
por: Dybkov, Olexandr, et al.
Publicado: (2023) -
Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitors
por: Shi, Yao, et al.
Publicado: (2021) -
Modulation of splicing catalysis for therapeutic targeting of leukemias with spliceosomal mutations
por: Lee, Stanley Chun-Wei, et al.
Publicado: (2016)